IQVIA and Veeva agree on long-term clinical and commercial partnerships
Global partnerships to help customers improve clinical and commercial efficiency and effectiveness
Read More
Section: Regulatory
Boehringer’s Hernexeos granted FDA accelerated approval for lung cancer patients
Approximately 226,650 lung cancer cases are expected to be diagnosed in the US this year
Read More
FDA approves Celltrion’s Actemra biosimilar Avtozma for cytokine release syndrome
Avtozma IV now fully aligns with all indications covered by Actemra IV in the US
Read More
AbbVie/Genmab’s lymphoma drug shows promise in phase 3 combination trial
Follicular lymphoma affects around 15,000 people in the US every year
Read More
FDA approves Jazz Pharmaceuticals’ Modeyso as first drug for ultra-rare brain cancer
H3 K27M-mutant diffuse midline glioma affects an estimated 2,000 people in the US every year
Read More